Incannex Healthcare Inc. 8-K

What Happened
Incannex Healthcare Inc. (IXHL) filed an 8-K on March 12, 2026 reporting a Securities Purchase Agreement for a registered direct offering expected to close on or about March 13, 2026. The company agreed to sell 1,997,285 common shares, pre‑funded warrants to buy up to 2,715 shares, and common stock warrants to purchase up to 2,000,000 shares. The combined purchase price is $5.00 per common share with an accompanying common warrant (and $4.9999 per pre‑funded warrant with an accompanying common warrant). Aggregate gross proceeds are expected to be approximately $10 million before placement agent fees and expenses.

Key Details

• Shares to be sold: 1,997,285 common shares; Pre‑Funded Warrants: up to 2,715; Common Warrants: up to 2,000,000.
• Pricing and exercise: common warrants exercisable for 5 years at $6.50 per share; pre‑funded warrants exercisable at $0.0001 per share.
• Ownership caps: Investors cannot exercise to own more than 4.99% (or elect 9.99%) of outstanding common stock immediately after exercise; investors can increase to up to 9.99% after 61 days’ prior notice.
• Placement agent and fees: Curvature Securities engaged as sole placement agent; fee of 7.0% of gross proceeds plus reimbursement of reasonable expenses and up to $100,000 in legal fees.
• Other items: 60‑day lockup on issuance/sale of common stock or equivalents; offering registered under Form S‑3 registration statements. Legal opinion from Mintz Levin attached.

Why It Matters
This filing indicates Incannex is raising capital and issuing warrants that, if exercised, would increase share count and could dilute existing shareholders. The transaction brings near‑term cash (about $10M gross) to the company but also includes a placement fee and potential future dilution if warrants are exercised. Investors should watch the closing of the offering, the actual net proceeds after fees, and any future exercises of the warrants that would affect outstanding share count and ownership percentages.